Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gyrus Group PLC, now operating as Gyrus ACMI under Olympus Corporation, is a leading medical technology company specializing in minimally invasive surgical solutions. The company is best known for its pioneering work in electrosurgery, particularly its proprietary PlasmaKinetic (PK) technology, which utilizes bipolar radiofrequency energy to cut and coagulate tissue with high precision. Gyrus's product portfolio primarily serves the surgical specialties of urology, gynecology, and otolaryngology (ENT). By integrating advanced visualization tools with energy-based instruments, Gyrus has significantly improved patient outcomes and reduced recovery times for various surgical procedures. Following its $3.6 billion acquisition by Olympus in 2008, Gyrus's technologies have become a cornerstone of Olympus's therapeutic solutions division. The company continues to drive innovation in the development of specialized instruments for endoscopic and laparoscopic surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gyrus.